These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17898126)

  • 41. Effect of GIP and GLP-1 antagonists on insulin release in the rat.
    Tseng CC; Zhang XY; Wolfe MM
    Am J Physiol; 1999 Jun; 276(6):E1049-54. PubMed ID: 10362617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meal-contingent intestinal lymph sampling from awake, unrestrained rats.
    Arnold M; Dai Y; Tso P; Langhans W
    Am J Physiol Regul Integr Comp Physiol; 2012 Jun; 302(12):R1365-71. PubMed ID: 22513747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.
    Jeppesen PB; Hartmann B; Thulesen J; Hansen BS; Holst JJ; Poulsen SS; Mortensen PB
    Gut; 2000 Sep; 47(3):370-6. PubMed ID: 10940274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats.
    Jessen L; Smith EP; Ulrich-Lai Y; Herman JP; Seeley RJ; Sandoval D; D'Alessio D
    Endocrinology; 2017 Jul; 158(7):2124-2133. PubMed ID: 28430981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digestive physiology of the pig symposium: involvement of gut chemosensing in the regulation of mucosal barrier function and defense mechanisms.
    Kaji I; Akiba Y; Kaunitz JD
    J Anim Sci; 2013 May; 91(5):1957-62. PubMed ID: 23345558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms.
    Balkan B; Li X
    Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1449-54. PubMed ID: 11004015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
    Vilsbøll T; Krarup T; Deacon CF; Madsbad S; Holst JJ
    Diabetes; 2001 Mar; 50(3):609-13. PubMed ID: 11246881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roux-en-Y gastric bypass surgery reprograms enterocyte triglyceride metabolism and postprandial secretion in rats.
    Kaufman S; Arnold M; Diaz AA; Neubauer H; Wolfrum S; Köfeler H; Langhans W; Krieger JP
    Mol Metab; 2019 May; 23():51-59. PubMed ID: 30905616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes.
    Lugari R; Dell'Anna C; Ugolotti D; Dei Cas A; Barilli AL; Zandomeneghi R; Marani B; Iotti M; Orlandini A; Gnudi A
    Horm Metab Res; 2000 Oct; 32(10):424-8. PubMed ID: 11069208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.
    Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B
    Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
    Toft-Nielsen MB; Madsbad S; Holst JJ
    Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion.
    Hagemann D; Holst JJ; Gethmann A; Banasch M; Schmidt WE; Meier JJ
    Regul Pept; 2007 Oct; 143(1-3):64-8. PubMed ID: 17434608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of portal glucose sensing on incretin hormone secretion in a canine model.
    Edgerton DS; Kraft G; Smith MS; Moore LM; Farmer B; Scott M; Moore MC; Nauck MA; Cherrington AD
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E244-E249. PubMed ID: 31112407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.